The global Pharmaceutical CDMO Solution market size was estimated at USD 128270 million in 2024 and is projected to reach USD 232193.85 million by 2032, exhibiting a CAGR of 7.70% during the forecast period.
North America Pharmaceutical CDMO Solution market size was estimated at USD 37980.99 million in 2024, at a CAGR of 6.60% during the forecast period of 2025 through 2032.
Report Overview
Pharmaceutical CDMO (Contract Development and Manufacturing Organization) solutions refer to the services offered by companies that provide end-to-end outsourcing services to the pharmaceutical industry. CDMOs partner with pharmaceutical companies to assist in various stages of drug development, from early-stage research and development (R&D) to commercial-scale manufacturing and distribution.
This report provides a deep insight into the global Pharmaceutical CDMO Solution market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmaceutical CDMO Solution Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmaceutical CDMO Solution market in any manner.
Global Pharmaceutical CDMO Solution Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Recipharm AB
- Lonza Group
- Catalent
- Patheon (Thermo Fisher Scientific)
- Siegfried AG
- SGS Quay Pharmaceuticals
- Curia
- Thermo Fisher Scientific
- Samsung Biologics
- Fujifilm Diosynth Biotechnologies
- Societal CDMO
- Aenova Group
- Eurofins CDMO
- Piramal Group
- WuXi AppTec Group
- Fareva
- Strides Pharma Science
- Famar Health Care Service
- WuXi Biologics
- Asymchem
- Pfizer CentreOne
- Including or Excluding key companies relevant to your analysis.
Market Segmentation (by Type)
- Active Pharmaceutical Ingredient (API) Manufacturing
- Finished Dosage Formulation (FDF) Development and Manufacturing
- Secondary Packaging
- Others
Market Segmentation (by Application)
- Pharmaceutical Company
- Biotechnology Company
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pharmaceutical CDMO Solution Market
- Overview of the regional outlook of the Pharmaceutical CDMO Solution Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pharmaceutical CDMO Solution
1.2 Key Market Segments
1.2.1 Pharmaceutical CDMO Solution Segment by Type
1.2.2 Pharmaceutical CDMO Solution Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pharmaceutical CDMO Solution Market Overview
2.1 Global Market Overview
2.1.1 Global Pharmaceutical CDMO Solution Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Pharmaceutical CDMO Solution Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pharmaceutical CDMO Solution Market Competitive Landscape
3.1 Global Pharmaceutical CDMO Solution Sales by Manufacturers (2019-2025)
3.2 Global Pharmaceutical CDMO Solution Revenue Market Share by Manufacturers (2019-2025)
3.3 Pharmaceutical CDMO Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmaceutical CDMO Solution Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Pharmaceutical CDMO Solution Sales Sites, Area Served, Product Type
3.6 Pharmaceutical CDMO Solution Market Competitive Situation and Trends
3.6.1 Pharmaceutical CDMO Solution Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmaceutical CDMO Solution Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pharmaceutical CDMO Solution Industry Chain Analysis
4.1 Pharmaceutical CDMO Solution Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pharmaceutical CDMO Solution Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pharmaceutical CDMO Solution Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmaceutical CDMO Solution Sales Market Share by Type (2019-2025)
6.3 Global Pharmaceutical CDMO Solution Market Size Market Share by Type (2019-2025)
6.4 Global Pharmaceutical CDMO Solution Price by Type (2019-2025)
7 Pharmaceutical CDMO Solution Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmaceutical CDMO Solution Market Sales by Application (2019-2025)
7.3 Global Pharmaceutical CDMO Solution Market Size (M USD) by Application (2019-2025)
7.4 Global Pharmaceutical CDMO Solution Sales Growth Rate by Application (2019-2025)
8 Pharmaceutical CDMO Solution Market Consumption by Region
8.1 Global Pharmaceutical CDMO Solution Sales by Region
8.1.1 Global Pharmaceutical CDMO Solution Sales by Region
8.1.2 Global Pharmaceutical CDMO Solution Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmaceutical CDMO Solution Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmaceutical CDMO Solution Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmaceutical CDMO Solution Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmaceutical CDMO Solution Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmaceutical CDMO Solution Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Pharmaceutical CDMO Solution Market Production by Region
9.1 Global Production of Pharmaceutical CDMO Solution by Region (2019-2025)
9.2 Global Pharmaceutical CDMO Solution Revenue Market Share by Region (2019-2025)
9.3 Global Pharmaceutical CDMO Solution Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Pharmaceutical CDMO Solution Production
9.4.1 North America Pharmaceutical CDMO Solution Production Growth Rate (2019-2025)
9.4.2 North America Pharmaceutical CDMO Solution Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Pharmaceutical CDMO Solution Production
9.5.1 Europe Pharmaceutical CDMO Solution Production Growth Rate (2019-2025)
9.5.2 Europe Pharmaceutical CDMO Solution Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Pharmaceutical CDMO Solution Production (2019-2025)
9.6.1 Japan Pharmaceutical CDMO Solution Production Growth Rate (2019-2025)
9.6.2 Japan Pharmaceutical CDMO Solution Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Pharmaceutical CDMO Solution Production (2019-2025)
9.7.1 China Pharmaceutical CDMO Solution Production Growth Rate (2019-2025)
9.7.2 China Pharmaceutical CDMO Solution Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Recipharm AB
10.1.1 Recipharm AB Pharmaceutical CDMO Solution Basic Information
10.1.2 Recipharm AB Pharmaceutical CDMO Solution Product Overview
10.1.3 Recipharm AB Pharmaceutical CDMO Solution Product Market Performance
10.1.4 Recipharm AB Business Overview
10.1.5 Recipharm AB Pharmaceutical CDMO Solution SWOT Analysis
10.1.6 Recipharm AB Recent Developments
10.2 Lonza Group
10.2.1 Lonza Group Pharmaceutical CDMO Solution Basic Information
10.2.2 Lonza Group Pharmaceutical CDMO Solution Product Overview
10.2.3 Lonza Group Pharmaceutical CDMO Solution Product Market Performance
10.2.4 Lonza Group Business Overview
10.2.5 Lonza Group Pharmaceutical CDMO Solution SWOT Analysis
10.2.6 Lonza Group Recent Developments
10.3 Catalent
10.3.1 Catalent Pharmaceutical CDMO Solution Basic Information
10.3.2 Catalent Pharmaceutical CDMO Solution Product Overview
10.3.3 Catalent Pharmaceutical CDMO Solution Product Market Performance
10.3.4 Catalent Pharmaceutical CDMO Solution SWOT Analysis
10.3.5 Catalent Business Overview
10.3.6 Catalent Recent Developments
10.4 Patheon (Thermo Fisher Scientific)
10.4.1 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Basic Information
10.4.2 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product Overview
10.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product Market Performance
10.4.4 Patheon (Thermo Fisher Scientific) Business Overview
10.4.5 Patheon (Thermo Fisher Scientific) Recent Developments
10.5 Siegfried AG
10.5.1 Siegfried AG Pharmaceutical CDMO Solution Basic Information
10.5.2 Siegfried AG Pharmaceutical CDMO Solution Product Overview
10.5.3 Siegfried AG Pharmaceutical CDMO Solution Product Market Performance
10.5.4 Siegfried AG Business Overview
10.5.5 Siegfried AG Recent Developments
10.6 SGS Quay Pharmaceuticals
10.6.1 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Basic Information
10.6.2 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product Overview
10.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product Market Performance
10.6.4 SGS Quay Pharmaceuticals Business Overview
10.6.5 SGS Quay Pharmaceuticals Recent Developments
10.7 Curia
10.7.1 Curia Pharmaceutical CDMO Solution Basic Information
10.7.2 Curia Pharmaceutical CDMO Solution Product Overview
10.7.3 Curia Pharmaceutical CDMO Solution Product Market Performance
10.7.4 Curia Business Overview
10.7.5 Curia Recent Developments
10.8 Thermo Fisher Scientific
10.8.1 Thermo Fisher Scientific Pharmaceutical CDMO Solution Basic Information
10.8.2 Thermo Fisher Scientific Pharmaceutical CDMO Solution Product Overview
10.8.3 Thermo Fisher Scientific Pharmaceutical CDMO Solution Product Market Performance
10.8.4 Thermo Fisher Scientific Business Overview
10.8.5 Thermo Fisher Scientific Recent Developments
10.9 Samsung Biologics
10.9.1 Samsung Biologics Pharmaceutical CDMO Solution Basic Information
10.9.2 Samsung Biologics Pharmaceutical CDMO Solution Product Overview
10.9.3 Samsung Biologics Pharmaceutical CDMO Solution Product Market Performance
10.9.4 Samsung Biologics Business Overview
10.9.5 Samsung Biologics Recent Developments
10.10 Fujifilm Diosynth Biotechnologies
10.10.1 Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Basic Information
10.10.2 Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Product Overview
10.10.3 Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Product Market Performance
10.10.4 Fujifilm Diosynth Biotechnologies Business Overview
10.10.5 Fujifilm Diosynth Biotechnologies Recent Developments
10.11 Societal CDMO
10.11.1 Societal CDMO Pharmaceutical CDMO Solution Basic Information
10.11.2 Societal CDMO Pharmaceutical CDMO Solution Product Overview
10.11.3 Societal CDMO Pharmaceutical CDMO Solution Product Market Performance
10.11.4 Societal CDMO Business Overview
10.11.5 Societal CDMO Recent Developments
10.12 Aenova Group
10.12.1 Aenova Group Pharmaceutical CDMO Solution Basic Information
10.12.2 Aenova Group Pharmaceutical CDMO Solution Product Overview
10.12.3 Aenova Group Pharmaceutical CDMO Solution Product Market Performance
10.12.4 Aenova Group Business Overview
10.12.5 Aenova Group Recent Developments
10.13 Eurofins CDMO
10.13.1 Eurofins CDMO Pharmaceutical CDMO Solution Basic Information
10.13.2 Eurofins CDMO Pharmaceutical CDMO Solution Product Overview
10.13.3 Eurofins CDMO Pharmaceutical CDMO Solution Product Market Performance
10.13.4 Eurofins CDMO Business Overview
10.13.5 Eurofins CDMO Recent Developments
10.14 Piramal Group
10.14.1 Piramal Group Pharmaceutical CDMO Solution Basic Information
10.14.2 Piramal Group Pharmaceutical CDMO Solution Product Overview
10.14.3 Piramal Group Pharmaceutical CDMO Solution Product Market Performance
10.14.4 Piramal Group Business Overview
10.14.5 Piramal Group Recent Developments
10.15 WuXi AppTec Group
10.15.1 WuXi AppTec Group Pharmaceutical CDMO Solution Basic Information
10.15.2 WuXi AppTec Group Pharmaceutical CDMO Solution Product Overview
10.15.3 WuXi AppTec Group Pharmaceutical CDMO Solution Product Market Performance
10.15.4 WuXi AppTec Group Business Overview
10.15.5 WuXi AppTec Group Recent Developments
10.16 Fareva
10.16.1 Fareva Pharmaceutical CDMO Solution Basic Information
10.16.2 Fareva Pharmaceutical CDMO Solution Product Overview
10.16.3 Fareva Pharmaceutical CDMO Solution Product Market Performance
10.16.4 Fareva Business Overview
10.16.5 Fareva Recent Developments
10.17 Strides Pharma Science
10.17.1 Strides Pharma Science Pharmaceutical CDMO Solution Basic Information
10.17.2 Strides Pharma Science Pharmaceutical CDMO Solution Product Overview
10.17.3 Strides Pharma Science Pharmaceutical CDMO Solution Product Market Performance
10.17.4 Strides Pharma Science Business Overview
10.17.5 Strides Pharma Science Recent Developments
10.18 Famar Health Care Service
10.18.1 Famar Health Care Service Pharmaceutical CDMO Solution Basic Information
10.18.2 Famar Health Care Service Pharmaceutical CDMO Solution Product Overview
10.18.3 Famar Health Care Service Pharmaceutical CDMO Solution Product Market Performance
10.18.4 Famar Health Care Service Business Overview
10.18.5 Famar Health Care Service Recent Developments
10.19 WuXi Biologics
10.19.1 WuXi Biologics Pharmaceutical CDMO Solution Basic Information
10.19.2 WuXi Biologics Pharmaceutical CDMO Solution Product Overview
10.19.3 WuXi Biologics Pharmaceutical CDMO Solution Product Market Performance
10.19.4 WuXi Biologics Business Overview
10.19.5 WuXi Biologics Recent Developments
10.20 Asymchem
10.20.1 Asymchem Pharmaceutical CDMO Solution Basic Information
10.20.2 Asymchem Pharmaceutical CDMO Solution Product Overview
10.20.3 Asymchem Pharmaceutical CDMO Solution Product Market Performance
10.20.4 Asymchem Business Overview
10.20.5 Asymchem Recent Developments
10.21 Pfizer CentreOne
10.21.1 Pfizer CentreOne Pharmaceutical CDMO Solution Basic Information
10.21.2 Pfizer CentreOne Pharmaceutical CDMO Solution Product Overview
10.21.3 Pfizer CentreOne Pharmaceutical CDMO Solution Product Market Performance
10.21.4 Pfizer CentreOne Business Overview
10.21.5 Pfizer CentreOne Recent Developments
11 Pharmaceutical CDMO Solution Market Forecast by Region
11.1 Global Pharmaceutical CDMO Solution Market Size Forecast
11.2 Global Pharmaceutical CDMO Solution Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pharmaceutical CDMO Solution Market Size Forecast by Country
11.2.3 Asia Pacific Pharmaceutical CDMO Solution Market Size Forecast by Region
11.2.4 South America Pharmaceutical CDMO Solution Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Pharmaceutical CDMO Solution by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Pharmaceutical CDMO Solution Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Pharmaceutical CDMO Solution by Type (2025-2032)
12.1.2 Global Pharmaceutical CDMO Solution Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Pharmaceutical CDMO Solution by Type (2025-2032)
12.2 Global Pharmaceutical CDMO Solution Market Forecast by Application (2025-2032)
12.2.1 Global Pharmaceutical CDMO Solution Sales (K Units) Forecast by Application
12.2.2 Global Pharmaceutical CDMO Solution Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmaceutical CDMO Solution Market Size Comparison by Region (M USD)
Table 5. Global Pharmaceutical CDMO Solution Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Pharmaceutical CDMO Solution Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Pharmaceutical CDMO Solution Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Pharmaceutical CDMO Solution Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Solution as of 2022)
Table 10. Global Market Pharmaceutical CDMO Solution Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Pharmaceutical CDMO Solution Sales Sites and Area Served
Table 12. Manufacturers Pharmaceutical CDMO Solution Product Type
Table 13. Global Pharmaceutical CDMO Solution Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pharmaceutical CDMO Solution
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmaceutical CDMO Solution Market Challenges
Table 22. Global Pharmaceutical CDMO Solution Sales by Type (K Units)
Table 23. Global Pharmaceutical CDMO Solution Market Size by Type (M USD)
Table 24. Global Pharmaceutical CDMO Solution Sales (K Units) by Type (2019-2025)
Table 25. Global Pharmaceutical CDMO Solution Sales Market Share by Type (2019-2025)
Table 26. Global Pharmaceutical CDMO Solution Market Size (M USD) by Type (2019-2025)
Table 27. Global Pharmaceutical CDMO Solution Market Size Share by Type (2019-2025)
Table 28. Global Pharmaceutical CDMO Solution Price (USD/Unit) by Type (2019-2025)
Table 29. Global Pharmaceutical CDMO Solution Sales (K Units) by Application
Table 30. Global Pharmaceutical CDMO Solution Market Size by Application
Table 31. Global Pharmaceutical CDMO Solution Sales by Application (2019-2025) & (K Units)
Table 32. Global Pharmaceutical CDMO Solution Sales Market Share by Application (2019-2025)
Table 33. Global Pharmaceutical CDMO Solution Sales by Application (2019-2025) & (M USD)
Table 34. Global Pharmaceutical CDMO Solution Market Share by Application (2019-2025)
Table 35. Global Pharmaceutical CDMO Solution Sales Growth Rate by Application (2019-2025)
Table 36. Global Pharmaceutical CDMO Solution Sales by Region (2019-2025) & (K Units)
Table 37. Global Pharmaceutical CDMO Solution Sales Market Share by Region (2019-2025)
Table 38. North America Pharmaceutical CDMO Solution Sales by Country (2019-2025) & (K Units)
Table 39. Europe Pharmaceutical CDMO Solution Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Pharmaceutical CDMO Solution Sales by Region (2019-2025) & (K Units)
Table 41. South America Pharmaceutical CDMO Solution Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Pharmaceutical CDMO Solution Sales by Region (2019-2025) & (K Units)
Table 43. Global Pharmaceutical CDMO Solution Production (K Units) by Region (2019-2025)
Table 44. Global Pharmaceutical CDMO Solution Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Pharmaceutical CDMO Solution Revenue Market Share by Region (2019-2025)
Table 46. Global Pharmaceutical CDMO Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Pharmaceutical CDMO Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Pharmaceutical CDMO Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Pharmaceutical CDMO Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Pharmaceutical CDMO Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Recipharm AB Pharmaceutical CDMO Solution Basic Information
Table 52. Recipharm AB Pharmaceutical CDMO Solution Product Overview
Table 53. Recipharm AB Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Recipharm AB Business Overview
Table 55. Recipharm AB Pharmaceutical CDMO Solution SWOT Analysis
Table 56. Recipharm AB Recent Developments
Table 57. Lonza Group Pharmaceutical CDMO Solution Basic Information
Table 58. Lonza Group Pharmaceutical CDMO Solution Product Overview
Table 59. Lonza Group Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Lonza Group Business Overview
Table 61. Lonza Group Pharmaceutical CDMO Solution SWOT Analysis
Table 62. Lonza Group Recent Developments
Table 63. Catalent Pharmaceutical CDMO Solution Basic Information
Table 64. Catalent Pharmaceutical CDMO Solution Product Overview
Table 65. Catalent Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Catalent Pharmaceutical CDMO Solution SWOT Analysis
Table 67. Catalent Business Overview
Table 68. Catalent Recent Developments
Table 69. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Basic Information
Table 70. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product Overview
Table 71. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Patheon (Thermo Fisher Scientific) Business Overview
Table 73. Patheon (Thermo Fisher Scientific) Recent Developments
Table 74. Siegfried AG Pharmaceutical CDMO Solution Basic Information
Table 75. Siegfried AG Pharmaceutical CDMO Solution Product Overview
Table 76. Siegfried AG Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Siegfried AG Business Overview
Table 78. Siegfried AG Recent Developments
Table 79. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Basic Information
Table 80. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product Overview
Table 81. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. SGS Quay Pharmaceuticals Business Overview
Table 83. SGS Quay Pharmaceuticals Recent Developments
Table 84. Curia Pharmaceutical CDMO Solution Basic Information
Table 85. Curia Pharmaceutical CDMO Solution Product Overview
Table 86. Curia Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Curia Business Overview
Table 88. Curia Recent Developments
Table 89. Thermo Fisher Scientific Pharmaceutical CDMO Solution Basic Information
Table 90. Thermo Fisher Scientific Pharmaceutical CDMO Solution Product Overview
Table 91. Thermo Fisher Scientific Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Thermo Fisher Scientific Business Overview
Table 93. Thermo Fisher Scientific Recent Developments
Table 94. Samsung Biologics Pharmaceutical CDMO Solution Basic Information
Table 95. Samsung Biologics Pharmaceutical CDMO Solution Product Overview
Table 96. Samsung Biologics Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Samsung Biologics Business Overview
Table 98. Samsung Biologics Recent Developments
Table 99. Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Basic Information
Table 100. Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Product Overview
Table 101. Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Fujifilm Diosynth Biotechnologies Business Overview
Table 103. Fujifilm Diosynth Biotechnologies Recent Developments
Table 104. Societal CDMO Pharmaceutical CDMO Solution Basic Information
Table 105. Societal CDMO Pharmaceutical CDMO Solution Product Overview
Table 106. Societal CDMO Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Societal CDMO Business Overview
Table 108. Societal CDMO Recent Developments
Table 109. Aenova Group Pharmaceutical CDMO Solution Basic Information
Table 110. Aenova Group Pharmaceutical CDMO Solution Product Overview
Table 111. Aenova Group Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Aenova Group Business Overview
Table 113. Aenova Group Recent Developments
Table 114. Eurofins CDMO Pharmaceutical CDMO Solution Basic Information
Table 115. Eurofins CDMO Pharmaceutical CDMO Solution Product Overview
Table 116. Eurofins CDMO Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. Eurofins CDMO Business Overview
Table 118. Eurofins CDMO Recent Developments
Table 119. Piramal Group Pharmaceutical CDMO Solution Basic Information
Table 120. Piramal Group Pharmaceutical CDMO Solution Product Overview
Table 121. Piramal Group Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 122. Piramal Group Business Overview
Table 123. Piramal Group Recent Developments
Table 124. WuXi AppTec Group Pharmaceutical CDMO Solution Basic Information
Table 125. WuXi AppTec Group Pharmaceutical CDMO Solution Product Overview
Table 126. WuXi AppTec Group Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 127. WuXi AppTec Group Business Overview
Table 128. WuXi AppTec Group Recent Developments
Table 129. Fareva Pharmaceutical CDMO Solution Basic Information
Table 130. Fareva Pharmaceutical CDMO Solution Product Overview
Table 131. Fareva Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 132. Fareva Business Overview
Table 133. Fareva Recent Developments
Table 134. Strides Pharma Science Pharmaceutical CDMO Solution Basic Information
Table 135. Strides Pharma Science Pharmaceutical CDMO Solution Product Overview
Table 136. Strides Pharma Science Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 137. Strides Pharma Science Business Overview
Table 138. Strides Pharma Science Recent Developments
Table 139. Famar Health Care Service Pharmaceutical CDMO Solution Basic Information
Table 140. Famar Health Care Service Pharmaceutical CDMO Solution Product Overview
Table 141. Famar Health Care Service Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 142. Famar Health Care Service Business Overview
Table 143. Famar Health Care Service Recent Developments
Table 144. WuXi Biologics Pharmaceutical CDMO Solution Basic Information
Table 145. WuXi Biologics Pharmaceutical CDMO Solution Product Overview
Table 146. WuXi Biologics Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 147. WuXi Biologics Business Overview
Table 148. WuXi Biologics Recent Developments
Table 149. Asymchem Pharmaceutical CDMO Solution Basic Information
Table 150. Asymchem Pharmaceutical CDMO Solution Product Overview
Table 151. Asymchem Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 152. Asymchem Business Overview
Table 153. Asymchem Recent Developments
Table 154. Pfizer CentreOne Pharmaceutical CDMO Solution Basic Information
Table 155. Pfizer CentreOne Pharmaceutical CDMO Solution Product Overview
Table 156. Pfizer CentreOne Pharmaceutical CDMO Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 157. Pfizer CentreOne Business Overview
Table 158. Pfizer CentreOne Recent Developments
Table 159. Global Pharmaceutical CDMO Solution Sales Forecast by Region (2025-2032) & (K Units)
Table 160. Global Pharmaceutical CDMO Solution Market Size Forecast by Region (2025-2032) & (M USD)
Table 161. North America Pharmaceutical CDMO Solution Sales Forecast by Country (2025-2032) & (K Units)
Table 162. North America Pharmaceutical CDMO Solution Market Size Forecast by Country (2025-2032) & (M USD)
Table 163. Europe Pharmaceutical CDMO Solution Sales Forecast by Country (2025-2032) & (K Units)
Table 164. Europe Pharmaceutical CDMO Solution Market Size Forecast by Country (2025-2032) & (M USD)
Table 165. Asia Pacific Pharmaceutical CDMO Solution Sales Forecast by Region (2025-2032) & (K Units)
Table 166. Asia Pacific Pharmaceutical CDMO Solution Market Size Forecast by Region (2025-2032) & (M USD)
Table 167. South America Pharmaceutical CDMO Solution Sales Forecast by Country (2025-2032) & (K Units)
Table 168. South America Pharmaceutical CDMO Solution Market Size Forecast by Country (2025-2032) & (M USD)
Table 169. Middle East and Africa Pharmaceutical CDMO Solution Consumption Forecast by Country (2025-2032) & (Units)
Table 170. Middle East and Africa Pharmaceutical CDMO Solution Market Size Forecast by Country (2025-2032) & (M USD)
Table 171. Global Pharmaceutical CDMO Solution Sales Forecast by Type (2025-2032) & (K Units)
Table 172. Global Pharmaceutical CDMO Solution Market Size Forecast by Type (2025-2032) & (M USD)
Table 173. Global Pharmaceutical CDMO Solution Price Forecast by Type (2025-2032) & (USD/Unit)
Table 174. Global Pharmaceutical CDMO Solution Sales (K Units) Forecast by Application (2025-2032)
Table 175. Global Pharmaceutical CDMO Solution Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Pharmaceutical CDMO Solution
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmaceutical CDMO Solution Market Size (M USD), 2019-2032
Figure 5. Global Pharmaceutical CDMO Solution Market Size (M USD) (2019-2032)
Figure 6. Global Pharmaceutical CDMO Solution Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmaceutical CDMO Solution Market Size by Country (M USD)
Figure 11. Pharmaceutical CDMO Solution Sales Share by Manufacturers in 2023
Figure 12. Global Pharmaceutical CDMO Solution Revenue Share by Manufacturers in 2023
Figure 13. Pharmaceutical CDMO Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pharmaceutical CDMO Solution Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical CDMO Solution Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pharmaceutical CDMO Solution Market Share by Type
Figure 18. Sales Market Share of Pharmaceutical CDMO Solution by Type (2019-2025)
Figure 19. Sales Market Share of Pharmaceutical CDMO Solution by Type in 2023
Figure 20. Market Size Share of Pharmaceutical CDMO Solution by Type (2019-2025)
Figure 21. Market Size Market Share of Pharmaceutical CDMO Solution by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pharmaceutical CDMO Solution Market Share by Application
Figure 24. Global Pharmaceutical CDMO Solution Sales Market Share by Application (2019-2025)
Figure 25. Global Pharmaceutical CDMO Solution Sales Market Share by Application in 2023
Figure 26. Global Pharmaceutical CDMO Solution Market Share by Application (2019-2025)
Figure 27. Global Pharmaceutical CDMO Solution Market Share by Application in 2023
Figure 28. Global Pharmaceutical CDMO Solution Sales Growth Rate by Application (2019-2025)
Figure 29. Global Pharmaceutical CDMO Solution Sales Market Share by Region (2019-2025)
Figure 30. North America Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Pharmaceutical CDMO Solution Sales Market Share by Country in 2023
Figure 32. U.S. Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Pharmaceutical CDMO Solution Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Pharmaceutical CDMO Solution Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Pharmaceutical CDMO Solution Sales Market Share by Country in 2023
Figure 37. Germany Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Pharmaceutical CDMO Solution Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Pharmaceutical CDMO Solution Sales Market Share by Region in 2023
Figure 44. China Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Pharmaceutical CDMO Solution Sales and Growth Rate (K Units)
Figure 50. South America Pharmaceutical CDMO Solution Sales Market Share by Country in 2023
Figure 51. Brazil Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Pharmaceutical CDMO Solution Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Pharmaceutical CDMO Solution Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Pharmaceutical CDMO Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Pharmaceutical CDMO Solution Production Market Share by Region (2019-2025)
Figure 62. North America Pharmaceutical CDMO Solution Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Pharmaceutical CDMO Solution Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Pharmaceutical CDMO Solution Production (K Units) Growth Rate (2019-2025)
Figure 65. China Pharmaceutical CDMO Solution Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Pharmaceutical CDMO Solution Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Pharmaceutical CDMO Solution Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Pharmaceutical CDMO Solution Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Pharmaceutical CDMO Solution Market Share Forecast by Type (2025-2032)
Figure 70. Global Pharmaceutical CDMO Solution Sales Forecast by Application (2025-2032)
Figure 71. Global Pharmaceutical CDMO Solution Market Share Forecast by Application (2025-2032)
